Meningococcal disease: Treatable but still terrifying

Internal Medicine Journal

Volumn 32, Issue 4, 2002, Pages 165-169

  Munro, Rosemary ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; MENINGOCOCCUS VACCINE; PENICILLIN G; POLYSACCHARIDE; PROTEIN C; RIFAMPICIN; VANCOMYCIN;

BACTERIUM CULTURE; CLINICAL FEATURE; GRAM NEGATIVE BACTERIUM; HUMAN; LABORATORY DIAGNOSIS; MENINGOCOCCOSIS; MORTALITY; NASOPHARYNX; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEPTICEMIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; NEW SOUTH WALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0036968576     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1444-0903.2001.00188.x     Document Type: Review

References (25)

1. Ashton FE, Ryan JA, Borczyk A, Caugant DA, Mancino L, Huang D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal disease in Canada. J Clin Microbiol 1994; 32: 1783-7.
2. Patel M. Meningococcal disease in Australia; looking at the past, thinking of the future. Commun Dis Intell 1997; 21: 233-6.
3. The Australian Meningococcal Surveillance Programme. Annual Report of the Australian Meningococcal Surveillance Programme, 1999. Commun Dis Intell 2000; 24: 181-9.
4. Jelfs J, Jalaludin B, Munro R et al. A cluster of meningococcal disease in western Sydney, Australia initially associated with a nightclub. Epidemiol Infect 1998; 120: 263-70.
5. Roche P, Spencer J, Merianos A. Meningococcal disease [editorial]. Commun Dis Intell 2001; 25: 126-9.
6. The Australian Meningococcal Surveillance Programme. Annual Report of the Australian Meningococcal Surveillance Programme, 2000. Commun Dis Intell 2001; 25: 113-21.
7. Steven N, Wood M. The clinical spectrum of meningococcal disease. In: Cartwright K, ed. Meningococcal Disease. Chichester: John Wiley and Sons; 1995; 177-205.
8. Van Dueren M, Brandtzaeg P, van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-66.
9. Jelfs J, Hughes BR, Gosbell IB. Purulent meningococcal pericarditis associated with Neisseria meningitidis MLST11, C.2a:P1.4. Proceedings of the 12th International Pathogenic Neisseria Meeting USA 2001; A327: 29.
10. Ploysangam T, Sheth AP. Chronic meningococcemia in childhood: case report and review of the literature. Paediatr Dermatol 1996; 13: 483-7.
11. Van Dueren M, van der Ven Jongkrijg J, Demacker PNM et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172: 433-9.
12. Scholten R, Bijlmer H, Valkenburg H, Dankert J. Patient and strain characteristics in relation to outcome of meningcoccal disease: a multivariate analysis. Epidemiol Infect 1994; 112: 115-24.
13. Munro R, Kociuba KK, Jelfs J, Brown J, Crone S, Chant K. Meningococcal disease in urban south western Sydney, 1990-94. Aust NZ J Med 1996; 26: 526-32.
14. Coll M-T, Uriz M-S, Pineda V et al. Meningococcal meningitis with 'normal' cerebrospinal fluid. J Infect 1994; 29: 289-94.
15. Porritt RJ, Mercer J, Munro R. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction. Pathology 2000; 32: 42-5.
16. Binotto E, Mercer J, Porritt R, Munro R. Rapid methods for the diagnosis of meningococcal disease. Proceedings of the Annual Scientific Meeting of the Australian Society for Microbiology (Perth WA) 2001; SY4.3: A11.
17. Robertson PW, Reinbott P, Duffy Y, Binotto E, Tapsall JW. Confirmation of invasive meningococcal disease by single point estimation of IgM antibody to outer membrane protein of Neisseria meningitidis. Pathology 2001; 33: 375-8.
18. National Neisseria Network of Australia. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia, 1994-1999. Pathology 2001; 33: 359-61.
19. Cartwright K, Strang J, Gossain S, Begg N. Early treatment of meningococcal disease. BMJ 1992; 305: 774.
20. Writing Group for Therapeutic Guidelines: Antibiotic. Therapeutic Guidelines: Antibiotic, 11th edn. Melbourne: Therapeutic Guidelines Ltd; 2000.
21. Schaad UB, Kaplan SL, McCracken GH Jr. Steroid therapy for bacterial meningitis. Clin Infect Dis 1995; 20: 685-90.
22. Alberio L, Lammle B, Esmon CT. Protein C replacement in severe meningococcemia: rationale and clinical experience. Clin Infect Dis 2001; 32: 1338-46.
23. Hastings L, Stuart J, Andrews N, Begg N. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in households and educational settings. Commun Dis Rep CDR Rev 1995; 7: R195-200.
24. Communicable Diseases Network Australia. Guidelines for the early clinical and public health management of meningococcal disease in Australia, June 2001. Commonwealth Department of Health and Aged Care, ACT. [cited XXX] Available at: URL http://www.health.gov.au/pubhlth/cdi/pubs/mening.htm
25. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001; 357: 195-6.